Home / Shop / GLP-1 Research Compounds / Tirzepatide
REF STANDARD NEW
Tirzepatide
Tirzepatide Reference Standard
Dual GLP-1/GIP Receptor Agonist · Research Use Only

Dual GLP-1/GIP agonist reference standard for receptor research.

Tirzepatide is a synthetic dual GLP-1 and GIP receptor agonist. Supplied as a reference standard for in vitro receptor binding, metabolic signaling, and comparative agonist studies. ≥99% purity by HPLC, LC-MS confirmed.

Quality Verification
≥99% Purity by HPLC
LC-MS Identity Confirmed
Endotoxin Tested (LAL)
Lyophilized Powder
Cold-Chain Shipped
Compound Specifications
CAS Number
2023788-19-2
Class
GLP-1/GIP Dual Agonist
Molecular Weight
~4,813 Da
Sequence
Dual Agonist Peptide
Form
Lyophilized Powder
Purity
≥99% by HPLC
Storage
−20°C lyophilized · 4°C reconstituted up to 7 days
Solubility
Sterile water with 0.1% acetic acid
Research Documentation
Read the Tirzepatide Research Overview →
→
Related Compounds
→Semaglutide →Retatrutide →GLP-1 Hub
Tirzepatide research peptide vial — Lone Star Peptide Co.
Certificate of Analysis included. Independent third-party batch verified.
Tirzepatide
Dual GLP-1/GIP Receptor Agonist · Research Use Only
Select Size
Price $89 / vial
Qty
1
🧪
Triple
Tested
📋
COA
Included
🚚
Same-Day
Houston

⚠ FOR RESEARCH USE ONLY, Tirzepatide is supplied exclusively for in vitro and laboratory research applications. Not approved by the FDA for human consumption or therapeutic use. Not a drug, supplement, or medical treatment. Purchasers are responsible for compliance with all applicable regulations.